Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2025 14:12 ET | Source: BCC Research LLC

mRNA Market Forecast: Small Decline of -0.04% CAGR by 2030

Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “mRNA: Therapeutics and Global Markets” is forecast to remain stable or slightly decline to $7.69 billion...
August 20, 2025 07:02 ET | Source: BCC Research LLC

Genome Editing Market to Grow at 16.9% CAGR Through 2030

Boston, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Genome Editing: Technologies and Global Markets” is projected to grow from $10.8 billion in 2025 to...
July 07, 2025 15:12 ET | Source: BCC Research LLC

DNA and RNA Sequencing Markets Set for Rapid Expansion, Says BCC Research

Boston, July 07, 2025 (GLOBE NEWSWIRE) -- BCC Research announces the release of its 2024 DNA and RNA Synthesis Research Review, offering detailed insights into the markets shaping genetic research...
June 26, 2025 16:30 ET | Source: ProQR Therapeutics N.V.

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

First-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy volunteers with initial data expected in Q4 2025Marks the first submitted...
April 10, 2025 09:31 ET | Source: BCC Research LLC

DNA Sequencing Industry Poised for Rapid Growth, Projected to Hit $34.8 Billion by 2029

Boston, April 10, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Global DNA Sequencing: Research, Applied and Clinical Markets” is expected to grow from $14.8 billion in...
October 16, 2024 13:00 ET | Source: DelveInsight Business Research LLP

80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight

New York, USA, Oct. 16, 2024 (GLOBE NEWSWIRE) -- 80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight With over 80 key companies active in the RNA therapies...
December 08, 2023 07:30 ET | Source: ProQR Therapeutics N.V.

ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets

Divestment of sepofarsen and ultevursen completed – Théa to continue development of sepofarsen and ultevursen for patients with LCA10 and Usher syndrome Agreement provides ProQR with initial payment...
December 22, 2022 06:15 ET | Source: ProQR Therapeutics N.V.

ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA...
December 22, 2022 06:00 ET | Source: ProQR Therapeutics N.V.

Lilly and ProQR to Expand RNA Editing Collaboration

INDIANAPOLIS; LEIDEN, Netherlands; and CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Eli Lilly and Company (NYSE: LLY) and ProQR Therapeutics N.V. (Nasdaq: PRQR), today announced the expansion...
September 12, 2022 18:30 ET | Source: Celsion Corporation

Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13

LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief...